This technology offers a revolutionary approach to point-of-care diagnosis and large-scale health surveillance by enabling portable, high-accuracy detection of proteins, bioparticles, and cells.
This invention encompasses processes, methods, kits, devices, and software for detecting proteins, particles, or cells in human or animal samples, potentially derived from viruses, bacteria, immune responses, or cancer cells. It includes portable imaging systems designed for use with microarrays or biochips, capable of supporting protein or bioparticle precipitates, and employing light sheet illumination for imaging in liquids. These systems are aimed at facilitating point-of-care diagnosis, immunity analysis, epidemiological surveillance, and the development of therapeutics and vaccines, particularly in the context of epidemics or pandemics.
· Point-of-care diagnostic devices for healthcare facilities and field use.
· Epidemiological surveillance and public health monitoring.
· Immunity analysis for vaccine development and therapeutic research.
· Education and research tools for biomedical studies.
· Enables point-of-care, high-accuracy diagnosis.
· Supports large-scale, high-throughput imaging.
· Portable and cost-effective, making advanced diagnostics accessible.
· Capable of detecting a wide range of health markers, including antibodies and antigens related to diseases like COVID-19.
· Designed for ease of manufacture and use in epidemic/pandemic response.
Country | Type | Number | Dated | Case |
Patent Cooperation Treaty | Reference for National Filings | WO 2021/216958 | 10/28/2021 | 2020-656 |
Patent Pending
fluorescence, microarrays, imaging, point-of-care devices, COVID-19, antibody testing, virus detection